Company intelligence / Profile preview

American BioOptics

Evanston, Illinois, United Statesmedtechinnovator.org ↗

Ownership: Private
Employees: ~7
Development stage: Other

Overview

American BioOptics has developed the InPoint System, a point-of-care optical diagnostic platform for rapid, minimally invasive colorectal cancer risk assessment. The system provides results in about 10 minutes and has demonstrated approximately 80% accuracy in over 600 patients for early identification of high-risk individuals needing further evaluation. It is designed to improve compliance and outcomes by enabling fast, cost-effective screening without preparation or sedation

Therapeutic areas: Oncology
Modalities: DeviceDiagnostic platform (optical technology)
Industry: Pathology

Partnerships

Northwestern University (technology origin/founders)

Beyond the preview

Go deeper on American BioOptics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on American BioOptics.

Explore the full profile